Form4insider filings, from the source

SEC Form 5 · accession 0001225208-17-003029

PORTOLA PHARMACEUTICALS INC · PTLA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 31, 2016
Accepted (ET)
Feb 13, 2017 · 6:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Jan 1, 2016G0$0.00D36,602IBy Ltd Partnership (NEST)
Common StockF2Oct 1, 2016G0$0.00D36,602IBy Ltd Partnership (NEST)
Common Stockholding———3,000D
Common StockF3holding———958,491IBy Ltd Partnership (SHV)
Common StockF4holding———59,053IBy Trust (Trustees)

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses